Medical Products Liability Posts in June, 2014

FDA Requires Makers of Testosterone Therapy to Include Warnings

 In June, the Food and Drug Administration (FDA) issued a statement requiring drug-makers who manufacture testosterone to issue a warning label on the drug regarding the potential risk for venous blood clots. Testosterone replacement drugs are a medicinal therapy for men with erectile dysfunction, though according to WebMD, “inadequate production of testosterone is not a common cause of ED.”...
Continue Reading »

FDA to Increase Access to Drug and Product Recall Information

The Food and Drug Administration (FDA) recently announced that it is conducting a pilot program to expedite drug recall notifications in an effort to quickly and efficiently relay important information to the public. The Agency, according to the FDA, currently issues a weekly Enforcement Report for consumers to be informed about the risks posed by products on the market....
Continue Reading »

A.S.R. Arthritic Treatment Reported Dangerous, Crippling

Arthritis can turn into a debilitating disease, no matter the age of the sufferer. However, arthritis patients can be medically treated to help continue with the performance of daily activities. One such arthritic treatment method is a hip replacement implant known as A.S.R. or the “articular surface replacement,” and it is manufactured by DePuy, a subsidiary of Johnson & Johnson....
Continue Reading »

Type 2 Diabetes Drugs Linked to Cancer

A recent study, published by, has found that a new class of diabetes treatment drugs may have serious side effects and are not necessarily being touted by the drug manufacturer or the doctors administering them. In April, AdverseEvents suggested a comparable safety research (CSR) study to offer a counterpoint to the report issued by the drug manufacturer....
Continue Reading »

ParaGard Intrauterine Contraceptive Devices Recalled

This April, a batch of ParaGard T 380A Intrauterine Copper Contraceptive devices were recalled due to a lack of assurance of sterility, according to the Food and Drug Administration (FDA). The device’s parent company, TEVA Pharmaceuticals which is based in Pennsylvania, voluntarily recalled the devices from hospitals, clinics, and gynecologists across the country....
Continue Reading »

FDA Approves New Crohn’s Disease Medical Treatment

Crohn’s disease is an inflammatory bowel disease and can affect any portion of the gastrointestinal tract from the mouth to the anus. If this is left untreated, a patient can suffer from diarrhea, vomiting, weight loss, skin rashes, abdominal pain, lack of concentration, tiredness, eye inflammation, and even arthritis. As a result of the pain and discomfort experienced by many Crohn’s patients, the search for a medical treatment has been widespread. However, a new medical treatment is on the horizon....
Continue Reading »

Talcum Powder Triples the Risk of Ovarian Cancer

Sometimes the most common household items can be the most dangerous products, often made even more so because information regarding their dangers is not widespread or readily available. One of these is talcum powder—commonly known as baby powder....
Continue Reading »

Morcellation Device Recalled

Morcellation devices are used to remove uterine fibroid growths that are common in women. They are non-cancerous growths that appear in the smooth muscle tissue in the uterus. If these fibroid growths are not removed, they can cause serious health issues for the affected women....
Continue Reading »
  • Newland & Newland LLP, Attorneys, Arlington Heights, IL